Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes - A biomarker for DNA damage in human populations

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 404, Issue 1-2, 1998, Pages 155-165

  Fenech, Michael ^a  

^a CSIRO   (Australia)

Author keywords

Age; Apoptosis; Cytokinesis block; Cytokinesis block method; Gender; Homocysteine; HUMN project; Lymphocyte; Micronucleus; Variable; Vitamin B12

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; HOMOCYSTEINE;

ADULT; AGE; AGED; APOPTOSIS; CONFERENCE PAPER; CYTOKINESIS; DEMOGRAPHY; DNA DAMAGE; FEMALE; GENOTOXICITY; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; MUTAGEN TESTING; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIVISION; CHROMOSOME BREAKAGE; CULTURE MEDIA; CYTOCHALASIN B; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; MUTAGENS; QUALITY CONTROL; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0032480029     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00109-2     Document Type: Conference Paper

References (34)

1. [1] M. Fenech, A.A. Morley, Measurement of micronuclei in human lymphocytes, Mutat. Res. 148 (1985) 29-36.
2. [2] M. Fenech, A.A. Morley, Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low-dose X-irradiation, Mutat. Res. 161 (1986) 193-198.
3. [3] M. Fenech, The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations, Environ. Health Perspect. 101 (1993) 101-107.
4. [4] M. Kirsch-Volders, A. Elhajouji, E. Cundari, P. Van Hummelen, The in vitro micronucleus test: a multi-end-point assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction, Mutat. Res. 392 (1997) 19-30.
5. [5] M. Fenech, The advantages and disadvantages of the cytokinesis-block micronucleus method, Mutat. Res. 392 (1997) 11-18.
6. [6] W.U. Muller, C. Streffer, Micronucleus assays, in: G. Obe (Ed.), Advances in Mutagenesis Research, Springer-Verlag, 1994, pp. 1-134.
7. [7] H.J. Evans, Historical perspectives on the development of the in vitro micronucleus test: a personal view, Mutat. Res. 392 (1997) 5-10.
8. [8] M. Kirsch-Volders, Towards a validation of the micronucleus test, Mutat. Res. 392 (1997) 1-4.
9. [9] M. Schuler, D.S. Rupa, D.A. Eastmond, A critical evaluation of centromeric labelling to distinguish micronuclei induced by chromosomal loss and breakage in vitro, Mutat. Res. 392 (1997) 81-95.
10. [10] M. Fenech, The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations, Environ. Health Perspect. 101 (1993) 101-107.
11. [11] C. Catena, D. Conti, P. Parasacchi, P. Marenco, B. Bortolato, M. Botturi, M. Leoni, M. Portaluri, P.G. Paleani-Vettori, E. Righi, Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy, Int. J. Radiat. Biol. 70 (1996) 301-308.
12. [12] T.J. Cheng, D.C. Christiani, X. Xu, J.C. Wain, J.K. Wiencke, K.T. Kelsey, Increased micronucleus frequency in lymphocytes from smokers with lung cancer, Mutat. Res. 349 (1996) 43-50.
13. [13] J. Surralles, A. Antoccia, A. Creus, F. Degrassi, F. Peris, C. Tanzarella, N. Xamena, R. Marcos, The effect of cytochalasin-B concentration on the frequency of micronuclei induced by four standard mutagens: results from two laboratories, Mutagenesis 9 (1994) 347-353.
14. [14] M. Fenech, The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations, Mutat. Res. 285 (1993) 35-44.
15. [15] J. Surrales, A.T. Natarajan, Human lymphocyte micronucleus assay in Europe: an international survey, Mutat. Res. 392 (1997) 165-174.
16. [16] K.L. Radack, S.M. Pinney, G.K. Livingston, Sources of variability in the human lymphocyte micronucleus assay: a population-based study, Environ. Mol. Mutagen. 26 (1995) 26-36.
17. [17] J.K. Brown, A. Williams, H.R. Withers, K.T. Ow, C. Gramacho, C. Amies, Sources of variability in the determination of micronuclei in irradiated peripheral blood lymphocytes, Mutat. Res. 389 (1997) 123-128.
18. [18] D. Anderson, A.J. Francis, P. Godbert, P.C. Jenkinson, K.R. Butterworth, Chromosome aberrations, sister chromatid exchanges and mitogen-induced blastogenesis in cultured peripheral blood lymphocytes from 48 control individuals sampled 8 times over two years, Mutat. Res. 250 (1991) 467-476.
19. [19] H. Motulsky, Intuitive Biostatistics, Oxford Univ. Press, 1995, pp. 195-204.
20. [20] C. Bolognesi, A. Abbondandolo, R. Barale, R. Casalone, L. Dalpra, M. Deferrari, F. Degrassi, A. Forni, L. Lamberti, C. Lando, L. Migliore, P. Padovani, R. Pasquini, R. Puntoni, L. Sbrana, M. Stella, S. Bonassi, Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations and micronuclei in human lymphocytes, Cancer Epidemiol. Biomarkers Prev. 6 (1997) 249-256.
21. [21] S. Ban, J.B. Cologne, S. Fujita, A.A. Awa, Radiosensitivity of atomic bomb survivors as determined with a micronucleus assay, Radiat. Res. 134 (1993) 170-178.
22. [22] M. Fenech, J. Rinaldi, A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians, Carcinogenesis 16 (1995) 223-230.
23. [23] M. Fenech, J. Rinaldi, The relationship between micronuclei in human lymphocytes and plasma levels of vitamin-C, vitamin-E, vitamin-B12 and folic acid, Carcinogenesis 15 (1994) 1405-1411.
24. [24] M. Fenech, I. Dreosti, C. Aitken, Vitamin-E supplements and their effect on vitamin-E status in blood and genetic damage rate in peripheral blood lymphocytes, Carcinogenesis 18 (1997) 359-364.
25. [25] M. Fenech, I.E. Dreosti, J.R. Rinaldi, Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men, Carcinogenesis 18 (1997) 1329-1336.
26. [26] C.J. Boushey, S.A.A. Beresford, G.S. Omenn, A.G. Motulsky, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes, JAMA 274 (1995) 1049-1057.
27. [27] G. Blundell, B.G. Jones, F.A. Rose, N. Tudball, Homocysteine mediated endothelial cell toxicity and its amelioration, Atherosclerosis 122 (1996) 163-172.
28. [28] H. Wang, M. Yoshizumi, K. Lai, J.C. Tsai, M.A. Perella, E. Haber, M.E. Lee, Inhibition of growth and p21 ras methylation in vascular endothelial cells by homocysteine but not cysteine, J. Biol. Chem. 272 (1997) 23580-25385.
29. [29] M. Fenech, G. Perepetskaya, L. Mikhalevich, A more comprehensive application of the micronucleus technique for biomonitoring of genetic damage rates in human populations: experiences from the Chernobyl catastrophe, Environ. Mol. Mutagen. 30 (1997) 112-118.
30. [30] D. Scott, J.B.P. Barber, E.L. Levine, W. Burril, S.A. Roberts, Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases amongst breast cancer patients: a test for predisposition, Br. J. Cancer 77 (1998) 614-620.
31. [31] P.A. Schulte, F.P. Perera, Validation, in: P.A. Schulte, F.P. Perera (Eds.), Molecular Epidemiology: Principles and Practices, Academic Press, 1993, pp. 79-107.
32. [32] P.A. Schulte, F. Perera, Transitional studies, in: P. Toniolo, P. Boffetta, D.E.G. Shuker, N. Rothman, B. Hulka, N. Pearce (Eds.), Application of Biomarkers in Cancer Epidemiology, IARC Scientific Publications No. 142, International Agency for Research on Cancer, Lyon, 1997, pp. 19-29.
33. [33] L. Hagmar, A. Brogger, I. Hansteen, S. Heim, B. Hogstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson, C. Reuterwall, S. Salomaa, S. Skerfving, M. Sorsa, Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the health risk of chromosome damage, Cancer Res. 54 (1994) 2919-2922.
34. [34] S. Bonassi, A. Abbondandolo, L. Camurri, L. Dal Pra, M. De Ferrari, F. Degrassi, A. Forni, L. Lamberti, C. Lando, P. Padovani, I. Sbrana, D. Vecchio, R. Puntoni, Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans?, Cancer Genet. Cytogenet. 79 (1995) 133-135.